M. Pérez-García

Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico

J. E. Muñoz-Medina, R. Gutiérrez-Ríos, S. Ávila-Ríos, 2022, Viruses.

Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City

S. Ávila-Ríos, R. Perez-Padilla, C. Arias, 2022, Vaccines.

Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Vaccinated and Unvaccinated Patients in Mexico City

R. Perez-Padilla, A. Hernández-Terán, M. Jiménez-Corona, 2022, medRxiv.

Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City

S. Ávila-Ríos, G. Reyes-Terán, Y. Caro-Vega, 2021, PloS one.

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico

J. E. Muñoz-Medina, R. Gutiérrez-Ríos, S. Ávila-Ríos, 2022, Microbiology spectrum.

High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018–2019

S. Ávila-Ríos, G. Reyes-Terán, L. Cruz, 2022, Open forum infectious diseases.

High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17.

S. Ávila-Ríos, G. Reyes-Terán, N. Farach, 2020, The Journal of antimicrobial chemotherapy.

HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: a sub-nationally representative survey

C. Magis-Rodríguez, S. Ávila-Ríos, G. Reyes-Terán, 2018, The Journal of antimicrobial chemotherapy.